Trial intelligence / Profile preview

Hydroxyurea in pediatric sickle cell anemia (BABY HUG)

NCT00006400Phase 3Completed

Sponsor
National Heart, Lung, and Blood Institute
Start
Aug 2000
Primary completion
Sep 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of hydroxyurea in sickle cell anemia (SCA), sponsored by National Heart, Lung, and Blood Institute. Started Aug 2000; status: completed.

02

Drugs

hydroxyurea
03

Conditions

sickle cell anemia (SCA)

Beyond the preview

Go deeper on NCT00006400.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00006400.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call